Related references
Note: Only part of the references are listed.Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Pragya D. Yadav et al.
CLINICAL INFECTIOUS DISEASES (2022)
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
Tyler N. Starr et al.
SCIENCE (2021)
The variant gambit: COVID-19's next move
Jessica A. Plante et al.
CELL HOST & MICROBE (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Florian Krammer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Matthew McCallum et al.
CELL (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
Emma C. Wall et al.
LANCET (2021)
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu et al.
NATURE (2021)
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann et al.
CELL REPORTS (2021)
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Tyler N. Starr et al.
CELL REPORTS MEDICINE (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY (2020)
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer et al.
EBIOMEDICINE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Syncytia formation by SARS-CoV-2-infected cells
Julian Buchrieser et al.
EMBO JOURNAL (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
Philip L. Tzou et al.
VIRUSES-BASEL (2020)
Nextstrain: real-time tracking of pathogen evolution
James Hadfield et al.
BIOINFORMATICS (2018)
Efficient generation of human IgA monoclonal antibodies
Valerie Lorin et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2015)